-
Assessing the Acceptance of Single-Arm Trials in Health Technology Appraisals: A Review of NICE, CADTH, HAS, and NCPE Appraisals in 2024
Mar 10, 2025, 14:00 PM -
The Unseen Progress: How PROs May Overlook the Value of Slowing Degenerative Decline
Mar 10, 2025, 14:00 PM -
Systematic Literature Review (SLR) of Disease Burden Related to First-Line (1L) Unresectable, Locally Advanced, or Metastatic Gastric Cancer (GC) and Gastroesophageal Junction (GEJ) Adenocarcinoma
Mar 10, 2025, 14:00 PM -
Prognostic or Predictive Factors in Biliary Tract Cancer: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Telehealth Use Among Adultswith Sickle Cell Disease in Texas Medicaid Before and During the Covid-19 Pandemic
Mar 10, 2025, 14:00 PM -
Trends in Attainment of the Kidney Health Evaluation for Patients With Diabetes Measure Among Insured Individuals in the US, 2021-2024
Mar 10, 2025, 14:00 PM -
A Systematic Review of Economic Evaluations of Healthcare Associated Infection Prevention and Control Interventions in Long Term Care Facilities
Mar 10, 2025, 14:00 PM -
Development and Psychometric Validation of Patient-Reported Outcome Measures for Masseter Muscle Prominence (MMP): The Lower Facial Shape Questionnaire
Mar 10, 2025, 14:00 PM -
Evaluation of Epidemiological Disease Burden of Endometriosis Based on Routinely Collected Health Data Between 2010 and 2019
Mar 10, 2025, 14:00 PM -
A European perspective on Health Resource Utilization (HRU) and Cost outcomes in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Talazoparib Plus Enzalutamide for HRR-Deficient Metastatic Castration-Resistant Prostate Cancer
Mar 10, 2025, 14:00 PM -
Assessing the Accuracy of Artificial Intelligence in Conducting Systematic Literature Reviews
Mar 10, 2025, 14:00 PM -
Depression Among Rheumatoid Arthritis Patients Using the Medical Expenditure Panel Survey Database
Mar 10, 2025, 14:00 PM -
Healthcare Cost and Resource Utilization among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US
Mar 10, 2025, 14:00 PM -
The Evolution of Language in Clinical Outcome Assessments- An Analysis of Source Wording Updates, Translation Updates, and the Need to Periodically Assess the Revelance of Linguistically Validated Translations
Mar 10, 2025, 14:00 PM -
Evolving Real-world Trends in Biomarker Testing for Bladder Cancer: A Comprehensive Retrospective Analysis from the US Community Oncology Setting (2015-2024)
Mar 10, 2025, 14:00 PM -
Development of Robust Comprehensive Code Lists to Ensure Consistency Across Global Real-World Evidence Studies
Mar 10, 2025, 14:00 PM -
Estimating the Potential Cost-Effectiveness of Long-Acting Naltrexone versus Oral Naltrexone for Alcohol Use Disorder
Mar 10, 2025, 14:00 PM -
Tremor Symptoms and Associated Activities of Daily Living Impacts in Essential Tremor: A Qualitative Concept Elicitation and Mapping Study
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Olaparib and Niraparib With Abiraterone Versus Abiraterone for First-Line Treatment of BRCA Mutated Metastatic Castration-Resistant Prostate Cancer in Taiwan
Mar 10, 2025, 14:00 PM
